Blood serum levels of amino-terminal pro-c-type natriuretic peptide in patients with systemic sclerosis

Connective Tissue Research

Volumn 51, Issue 2, 2010, Pages 83-87

  Olewicz Gawlik, Anna ^a   Danczak Pazdrowska, Aleksandra ^a   Klama, Kamilla ^a   Silny, Wojciech ^a   Prokop, Janusz ^a   MacKiewicz, Stefan ^a   Grala, Pawel ^a   Hrycaj, Pawel ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

C type natriuretic peptide; Endothelium; Inflammation; Selectins; Systemic sclerosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMINO TERMINAL PRO C BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; IMMUNOSUPPRESSIVE AGENT; NATRIURETIC PEPTIDE TYPE C; SELECTIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; MALE; PATHOGENESIS; PILOT STUDY; PROTEIN BLOOD LEVEL; SYSTEMIC SCLEROSIS;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DISEASE PROGRESSION; E-SELECTIN; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, C-TYPE; P-SELECTIN; PILOT PROJECTS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 77649334839     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.3109/03008200903056168     Document Type: Article

References (21)

1. Abraham, D.J., and Varga, J. (2005). Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol., 26, 587-595.
2. Sudoh, T., Minamino, N., Kangawa, K., and Matsuo, H. (1990). C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun., 168, 863-870.
3. Stingo, A.J., Clavell, A.L., Heublein, D.M., Wei, C.M., Pittelkow, M.R., and Burnett, J.C. Jr. (1992). Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am. J. Physiol., 263, H1318-H1321.
4. Nakamura, M., Arakawa, N., Yoshida, H., Makita, S., and Hiramori, K. (1994). Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure. Circulation, 90, 1210-1214.
5. Prickett, T.C., Yandle, T.G., Nicholls, M.G., Espiner, E.A., and Richards, A.M. (2001). Identification of amino-terminal pro-C-type natriuretic peptide in human plasma. Biochem. Biophys. Res. Commun., 286, 513-517.
6. Scotland, R.S., Cohen, M., Foster, P., Lovell, M., Mathur, A., Ahluwalia, A., and Hobbs, A.J. (2005). C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression. Proc. Natl. Acad. Sci. USA, 102, 14452-14457.
7. Ahluwalia, A., Cohen, M., Scotland, R., and Hobbs, A. (2004). C-type natriuretic peptide (CNP) inhibits thrombin-induced platelet aggregation. Br. J. Pharmacol., pA2 online2, 024C.
8. Kohno, M., Horio, T., Yokokawa, K., Kurihara, N., and Takeda, T. (1992). C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3′,5′-monophosphate. Hypertension, 19, 320-325.
9. Masi, A.T., Rodnan, G.P., Medsger, T.A., Altman, R.D., D'Angelo, W.A., Fries, J.F., Leroy, E.C., Kirsner, A.B., MacKenzie, A.H., McShane, D.J., Myers, A.R., and Sharp, G.C. (1980). Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthr. Rheum., 23, 581-590.
10. LeRoy, E.C., Black, C., Fleischmajer, R., Jablonska, S., Krieg, T., Medsger, T.A. Jr, Rowell, N., and Wollheim, F. (1988). Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol., 15, 202-205.
11. Clements, P., Lachenbruch, P., Siebold, J., White, B., Weiner, S., Martin, R., Weinstein, A., Weisman, M., Mayes, M., Collier, D., Wigley, F., Medsger, T., Steen, V., Moreland, L., Dixon, M., Massa, M., Lally, E., McCloskey, D., Varga, J., Ingenito, F., and Furst, D. (1995). Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J. Rheumatol., 22, 1281-1285.
12. Akesson, A., Fiori, G., Krieg, T., van den Hoogen, F.H., and Seibold, J.R. (2003). Assessment of skin, joint, tendon and muscle involvement. Clin. Exp. Rheumatol., 21(3 suppl 29), S5-S8.
13. Kansas, G.S. (1996). Selectins and their ligands: current concepts and controversies. Blood, 88, 3259-3287.
14. Ateş, A., Kinikli, G., Turgay, M., and Duman, M. (2004). Serum-soluble selectin levels in patients with rheumatoid arthritis and systemic sclerosis. Scand. J. Immunol., 59, 315-320.
15. Qian, J.Y., Haruno, A., Asada, Y., Nishida, T., Saito, Y., Matsuda, T., and Ueno, H. (2002). Local expression of C-type natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arteries. Circ. Res., 91, 1063-1069.
16. Ohta, S., Shimekake, Y., and Nagata, K. (1996). Molecular cloning and characterization of a transcription factor for the C-type natriuretic peptide gene promoter. Eur. J. Biochem., 242, 460-466.
17. Mendonça, M.C., Doi, S.Q., Glerum, S., and Sellitti, D.F. (2006). Increase of C-type natriuretic peptide expression by serum and platelet-derived growth factor-BB in human aortic smooth muscle cells is dependent on protein kinase C activation. Endocrinology, 147, 4169-4178.
18. Ishiwata, N., Takio, K., Katayama, M., Watanabe, K., Titani, K., Ikeda, Y., and Handa, M. (1994). Alternatively spliced isoform of P-selectin is present in vivo as a soluble molecule. J. Biol. Chem., 269(38), 23708-23715.
19. Kamath, S., Blann, A.D., Caine, G.J., Gurney, D., Chin, B.S., and Lip, G.Y. (2002). Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation. Stroke, 33, 1237-1242.
20. Yamane, K., Ihn, H., Kubo, M., Yazawa, N., Kikuchi, K., Soma, Y., and Tamaki, K. (2000). Increased serum levels of soluble vascular cell adhesion molecule 1 and E-selectin in patients with localized scleroderma. J. Am. Acad. Dermatol., 42, 64-69.
21. Wyble, C.W., Hynes, K.L., Kuchibhotla, J., Marcus, B.C., Hallahan, D., and Gewertz, B.L. (1997). TNF-alpha and IL-1 upregulate membrane-bound and soluble E-selectin through a common pathway. J. Surg. Res., 73, 107-112.